Penny Stock News Revive Therapeutics Signs MOU with Attwill Medical Solutions for Phase 3 Clinical Trial for Bucillamine in COVID-19 TORONTO, Aug. 14, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or… August 14, 20204 minute read
Penny Stock News Revive Therapeutics Advancing Drug Delivery Technology for Psychedelics Developed Prototypes of Orally Dissolvable Thin Film For Psilocybin TORONTO, Aug. 11,… August 11, 20204 minute read
Penny Stock News Revive Therapeutics Update Following U.S. FDA Approval of Phase 3 Clinical Trial for Bucillamine in COVID-19 TORONTO, Aug. 05, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or… August 5, 20206 minute read
Featured Penny Stock News Can You Make Money With Penny Stocks? 3 Making New Highs These Penny Stocks Took May By Storm & Just Made New Highs… May 22, 20206 minute read
